Traws PharmaTRAW
13F holders, Q3 2024 (September 30)1holders −29
0new positions
19sold out
$5.00avg. 13F price*
At the end of Q3 2024, 1 institutions reported holding Traws Pharma Inc. (TRAW) in their 13F filings, down 29 from Q2 2024. 0 opened new positions and 19 sold out. The largest holder was Cornerstone Planning Group LLC ($5).
- Company
- Traws Pharma Inc.
- CUSIP
- 68232V801
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 19 | $404K |
All 13F filers, Q2 2024 → Q3 2024: 904,998 shares sold, net −904,998 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Cornerstone Planning Group LLC | 0.00% | Reduce -97.0% | 1 | $5 |
"% of holder's portfolio" is TRAW's weight in each manager's 13F, not the share of Traws Pharma Inc. the manager owns.